Press Releases

 
May 13, 2013
MENTOR supports “Beauty Through Science” Conference

MENTOR Gold Sponsors at “Beauty Through Science” Conference, Stockholm
 
 MENTOR are proud to be ‘Gold Sponsors’ at the upcoming Beauty through Science conference in Stockholm, Sweden 29-31st May 2013. As part of Mentor’s ongoing commitment to medical education, Mentor will be sponsoring a lunchtime symposium entitled “Why QUALITY Matters, New Perspectives in Patient Safety” on Thursday 30th May from 12.00-13.00 in the Main Session. Our distinguished faculty of experts will discuss how the importance of quality, demonstrated through robust clinical evidence, influences the choices surgeons make in terms of improving patient safety and outcomes in their practice. Learn more about Mentor’s commitment to quality at our exhibition booth (N°14,15,16) and get hands-on experience with our leading breast implants.
 
About Beauty through Science:
The Beauty through Science conference is a revered scientific meeting chaired by Prof. Per Hedén covering the latest developments and evolutions in Aesthetic Medicine. The event has been running for the past 11 years and is an annual event. 900 participants are expected to attend the meeting making it one of the leading top quality scientific meetings attracting international KOLs. At the heart of the scientific program is Plastic Surgery, with special focus on Aesthetic Breast Surgery.
 
About Mentor Worldwide LLC
Mentor Worldwide LLC is a leading supplier of medical products for the global aesthetic medicine market. Mentor develops, manufactures and markets innovative, science-based products for aesthetics markets around the world. Our commitment to the surgeons and patients who use our products is to provide the highest standard of quality, proven safe and effective clinical outcomes and differentiated service, everyday. This is at the core of who we are as the leader in breast aesthetics, built upon our 50 year dedication and our long term commitment to advance plastic surgery to restore body and life.
 
October 17, 2012
Mentor supports BRA Day

Mentor supports Breast Reconstruction Awareness Day to foster awareness of post-cancer reconstruction options for women - Closing the loop on breast cancer care
 
17 October 2012 - Mentor Worldwide LLC, leading global manufacturer of the highest quality breast implants, is proud to announce its support for Breast Reconstruction Awareness Day (BRA) taking place today Wednesday 17th October.
 
Breast cancer is the most common cancer in European women with an estimated 430,000 new cases every year . Facing treatment can be a frightening and stressful experience, with surgery often resulting in significant alterations to a woman’s breast. Recovery from the disease poses its own significant challenges, which are often compounded by changes to a woman's physical appearance and the resulting impact this can have on her quality of life.
 
Breast reconstruction in post-mastectomy women can play a critial role in aiding recovery, well-being and improving self-esteem. It is estimated, however, that 43% of women are not informed of their reconstruction options at the time of diagnosis, and are therefore unaware of the positive benefits.
 
As Mr. Jian Farhadi, Consultant Plastic Surgeon and Head of Department of Plastic Surgery at Guy’s and St. Thomas Hospital, London says,
 
“Breast reconstruction is a woman's right in order to maintain and regain her quality of life when facing breast cancer and mastectomy.”
 
Recognising the low-levels of awareness about the benefits of breast reconstruction, Dr. Mitchell Brown, a Canadian plastic surgeon specialising in aesthetic and reconstructive breast surgery, launched BRA Day, to ‘close the loop on breast cancer’.
 
Dr. Brown commented, ‘Once women are diagnosed and receive treatment, which sometimes includes mastectomy, they are not often aware of the options available to them. We aim to ensure that educating breast cancer patients at the time of diagnosis is an essential element of their treatment. BRA Day is also a vehicle that will help communicate the positive effects that breast reconstruction has on the quality of life for post-mastectomy women and normalize the conversation.”
 
As the leader in the global aesthetic and reconstructive surgery marketplace, Mentor Worldwide LLC understands that reconstruction is not just replacement, but restores a woman’s self-esteem in a safe and effective way. Making reconstruction a key part of the journey to recovery signifies a return to feeling and a sense of completeness that can have a profound effect on health outcomes and quality of life. Research has found that breast reconstruction immediately following a mastectomy is connected to higher survival rates, which is attributed to the patient‘s improved self-esteem and sense of wellbeing.
 
David Atkins, International Vice President, Mentor, said, “Mentor fully supports the goal of BRA Day to educate women dealing with breast cancer on their options post-surgery in a safe and timely manner. With over 50 years of combined breast aesthetics excellence, we are committed to helping women improve their self-esteem and regain their quality of life by providing safe and reliable products that meet the highest industry standards of design and testing.”
 
Mentor is also helping to raise awareness during Breast Cancer Awareness Month, by encouraging women to take action and download a self-exam card from our website.
 
For more information on reconstruction possibilities, visit the website www.yourbreastoptions.co.uk
 
Read More
 
JANUARY 15, 2012
Mentor Statement on PIP Breast Implants

 
Read More
 
JANUARY 27, 2011
MENTOR STATEMENT:

Mentor’s first priority has and always will be patient safety. We fully support the U.S. Food and Drug Administration’s (FDA) efforts to gather additional data and study ALCL (anaplastic large cell lymphoma) in patients with breast implants.
 
According to today’s FDA report, there are about “60 ALCL cases worldwide [though] that number is difficult to verify.” FDA also estimates that 5 to 10 million women worldwide have breast implants. Mentor has been monitoring very closely case reports of patients with ALCL, (a rare form of non-Hodgkins lymphoma) since reports first appeared in the medical literature regarding this condition. Mentor has provided and continues to provide information to FDA and other regulatory agencies about the safety of its products.
 
Mentor concurs with FDA’s position that, “because the risk of ALCL appears very small, FDA believes that the totality of evidence continues to support a reasonable assurance that FDA-approved breast implants are safe and effective when used as labeled.”
Read More